Newly established Focal Biosciences will focus on bringing together leading experts and scientific discoveries to harness cellular reprogramming in the fight against common age-related diseases.
The Paul Scherrer Institute PSI and the start-up AlphaSYNT are piloting a new approach for storing energy in the form of methane gas.
Researchers have shown that mirror-image substances – so-called enantiomers – can be better distinguished using helical X-ray light.
Researchers have measured and determined the sources of aerosol pollution at 22 locations in Europe.
PSI researchers have developed a new substance that disables a vital protein in the cell skeleton.
PSI researchers are the first to observe a specific behaviour of magnetic ice.
PSI develops a revolutionary achromatic lens for X-rays.
The test identifies different virus variants and improves disease prognosis.
In pursuit of particularly stable quantum bits, researchers have closely examined the electron distribution in two semiconductors.
PSI scientists have shed light on the structure of an important component of the eye: CNG ion channels whose job is to relay optical signals to the brain.
Boosted with superconductivity: Semiconductor technology can get a new twist by exploiting quantum effects in superconductors.
Kantonsspital Baden and the Paul Scherrer Institute PSI have signed a cooperation agreement.
25 November 1996: a world first for PSI’s Center for Proton Therapy in treating a cancer patient using the spot-scanning technique.
On 9 November 2021 a lung cancer patient was given proton therapy at the Paul Scherrer Institute PSI for the first time in Switzerland.